Impact of the COVID-19 pandemic on patients with systemic lupus erythematosus: Observations from an Indian inception cohort

被引:31
作者
Rathi, Manish [1 ]
Singh, Parmeshar [1 ]
Bi, Hayath Peta [2 ]
Shivanna, Archana [3 ]
Kavadichanda, Chengappa [4 ]
Tripathy, Saumya Ranjan [5 ]
Parthasarathy, Janani [6 ]
Tota, Sneha [7 ]
Maurya, Supriya [7 ]
Vijayalekshmi, Vishnupriya [8 ]
Bhavani, D. [2 ]
Jain, Avinash [9 ]
Gupta, Ranjan [8 ]
Danda, Debashish [6 ]
Rajasekhar, Liza [2 ]
Negi, Vir Singh [4 ]
Shobha, Vineeta [3 ]
Das, Bidyut [5 ]
Aggarwal, Amita [8 ]
机构
[1] Postgrad Inst Med Educ & Res, Dept Nephrol, Chandigarh, India
[2] Nizam Inst Med Sci, Dept Rheumatol, Hyderabad, India
[3] St Johns Med Coll Hosp, Dept Clin Immunol & Rheumatol, Bengaluru, India
[4] JIPMER, Dept Clin Immunol, Pondicherry, India
[5] SCB Med Coll, Dept Rheumatol, Cuttack, India
[6] Christian Med Coll & Hosp, Dept Clin Immunol & Rheumatol, Vellore, Tamil Nadu, India
[7] Sanjay Gandhi Postgrad Inst Med Sci, Dept Clin Immunol & Rheumatol, Lucknow, Uttar Pradesh, India
[8] All India Inst Med Sci, Dept Rheumatol, New Delhi, India
[9] SMS Med Coll & Hosp, Dept Med, Div Clin Immunol & Rheumatol, Jaipur, Rajasthan, India
关键词
Cohort; pandemic; Corona virus; Hydroxychloroquine; CLINICAL-COURSE; SERIES;
D O I
10.1177/0961203320962855
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction The ongoing pandemic of COVID-19 has led to severe disruption of healthcare services worldwide. We conducted this study to assess the impact of COVID-19 pandemic on the management of Systemic Lupus Erythematosus (SLE) patients who were enrolled in the nation-wide inception cohort. Methods A questionnaire was administered to the SLE patients enrolled in the inception cohort. Questions related to the effect on disease activity, preventive measures adopted against COVID-19, the incidence of COVID-19, hardships faced in getting access to health care professionals and availability of medicines, adherence, fear of COVID-19 and the potential benefits of being part of the registry. Results A total of 1040 (90% females) patients completed the questionnaire. The mean age was 27.5 +/- 19.1 years and the mean disease duration was 1.25 years. Twenty-Four (2.3%) patients had developed fever (>1 day) during this period, including one patient with additional symptoms of diarrhoea and anosmia, however, none of the patients developed COVID-19 infection. 262 patients (25.2%) reported financial difficulty during this period and patients reported an average excess expenditure of at least 2255.45 INR ($30) per month. 378 patients (36%) reported problems in getting their prescribed medicines due to lockdown. Of these, 167 (40%) patients needed to change their medication schedule due to this non-availability. Almost 54% of patients missed their scheduled follow up visits during the lockdown period and 37% of patients were unable to get their investigations done due to closure of laboratories and hospitals. 266 patients (25.5%) reported worsening of various symptoms of SLE during this period. Almost 61% patients felt confident that being associated with the inception cohort had helped them in managing their disease better during this period of lockdown as they received help in the form of timely and frequent telephonic consults, assistance in making the medicines available, and regular counselling resulting in abetment of their fears and anxieties. Conclusion The current COVID-19 pandemic has made a huge impact on our SLE patients. Patients faced difficulty in the availability of medicines, missed the doses of medicines, had financial constraints, and spent more money on health during the pandemic.
引用
收藏
页码:158 / 164
页数:7
相关论文
共 23 条
[1]   Incidence and Clinical Course of COVID-19 in Patients with Connective Tissue Diseases: A Descriptive Observational Analysis [J].
Favalli, Ennio Giulio ;
Agape, Elena ;
Caporali, Roberto .
JOURNAL OF RHEUMATOLOGY, 2020, 47 (08) :1296-1296
[2]  
Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI [10.1016/j.ijantimicag.2020.105949, 10.1016/j.ijantimicag.2020.106063]
[3]   Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry [J].
Gianfrancesco, Milena ;
Hyrich, Kimme L. ;
Al-Adely, Sarah ;
Carmona, Loreto ;
Danila, Maria, I ;
Gossec, Laure ;
Izadi, Zara ;
Jacobsohn, Lindsay ;
Katz, Patricia ;
Lawson-Tovey, Saskia ;
Mateus, Elsa F. ;
Rush, Stephanie ;
Schmajuk, Gabriela ;
Simard, Julia ;
Strangfeld, Anja ;
Trupin, Laura ;
Wysham, Katherine D. ;
Bhana, Suleman ;
Costello, Wendy ;
Grainger, Rebecca ;
Hausmann, Jonathan S. ;
Liew, Jean W. ;
Sirotich, Emily ;
Sufka, Paul ;
Wallace, Zachary S. ;
Yazdany, Jinoos ;
Machado, Pedro M. ;
Robinson, Philip C. .
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (07) :859-866
[4]  
Government of India, 2020, REV ADV US HYDR HCQ
[5]   Impact of COVID-19 pandemic on patients with SLE: results of a large multicentric survey from India [J].
Goyal, Mohit ;
Patil, Pravin ;
Pathak, Himanshu ;
Santhanam, Sham ;
Goel, Anshul ;
Sharma, Vishnu ;
Pandey, Akshat ;
Gupta, Nikhil ;
Jain, Rahul ;
Akerkar, Shashank ;
Das, Parthajit ;
Dudam, Rajkiran ;
Mendiratta, Naval ;
Pandey, Bimlesh Dhar ;
Mithun, C. B. ;
Singh, Bharat K. ;
Kumar, Sharath ;
Nolkha, Nilesh ;
Jain, Shriyanka ;
Jain, Somya ;
Sharma, Ashish ;
Misra, Durga Prasanna .
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (05)
[6]   Impact of COVID-19 pandemic on SLE: beyond the risk of infection [J].
Horisberger, Alice ;
Moi, Laura ;
Ribi, Camillo ;
Comte, Denis .
LUPUS SCIENCE & MEDICINE, 2020, 7 (01)
[7]   A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19 [J].
Kim, Alfred H. J. ;
Sparks, Jeffrey A. ;
Liew, Jean W. ;
Putman, Michael S. ;
Berenbaum, Francis ;
Duarte-Garcia, Ali Prime ;
Graef, Elizabeth R. ;
Korsten, Peter ;
Sattui, Sebastian E. ;
Sirotich, Emily ;
Ugarte-Gil, Manuel F. ;
Webb, Kate ;
Grainger, Rebecca .
ANNALS OF INTERNAL MEDICINE, 2020, 172 (12) :819-+
[8]  
Littlejohn Emily, 2020, Cleve Clin J Med, DOI 10.3949/ccjm.87a.ccc023
[9]   Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro [J].
Liu, Jia ;
Cao, Ruiyuan ;
Xu, Mingyue ;
Wang, Xi ;
Zhang, Huanyu ;
Hu, Hengrui ;
Li, Yufeng ;
Hu, Zhihong ;
Zhong, Wu ;
Wang, Manli .
CELL DISCOVERY, 2020, 6 (01)
[10]   The Role of Chloroquine and Hydroxychloroquine in Immune Regulation and Diseases [J].
Martinez, Gricelis P. ;
Zabaleta, Mercedes E. ;
Di Giulio, Camilo ;
Charris, Jaime E. ;
Mijares, Michael R. .
CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (35) :4467-4485